This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
The Zacks Analyst Blog Highlights EWJ, SPY, OPPJ, FJP, JPXN, SCJ and DFJ
by Zacks Equity Research
EWJ and other Japan ETFs jump to 52-week highs as the Nikkei tops 57,000 on Prime Minister Takaichi's landslide win.
Japan ETFs Soar on "Takaichi Trade": Top-Performers in Focus
by Sanghamitra Saha
Japan ETFs rally as "Takaichi Trade" lifts Nikkei to record highs. Stimulus hopes, reform optimism and growth bets drive strong gains across funds.
Japan ETFs Rising: Here's Why
by Sanghamitra Saha
Nikkei 225's rally, fueled by U.S. rate cut hopes, trade truces, and Japan's pro-investment policies, is boosting demand for Japan-focused ETFs like EWJ and JPXN.
Buffett Bets Big on Japan: ETFs to Play
by Sanghamitra Saha
Warren Buffett's Berkshire Hathaway remains dedicated to its Japanese investments for the long term and has secured an agreement with the five companies to exceed its initial 10% ownership cap lately.
Japan ETFs Beating S&P 500: More Growth in the Cards?
by Sanghamitra Saha
Japan ETFs have been surging over the past year on several factors and beating the S&P 500.
Japan Topix Hits 30-Year High: ETFs to Tap
by Sweta Killa
The Japan Topix Index climbed to the highest level since April 1991 and has been outperforming its Asian peers in recent weeks.
Is It Time to Buy Japan ETFs as Nikkei at About 30-Year High?
by Sanghamitra Saha
Japanese shares were hovering near a 30-year high on Dec 9 courtesy of global market optimism.
Japan ETFs Rally on BoJ's Hints of Easing in October
by Sanghamitra Saha
BoJ could ease polices further in October. The prospective move could help Japan ETFs.
What's in Store for Japan ETFs
by Zacks Equity Research
Japan's inflation dips in March. However, economists suggest this is not a reversal in trend.
BoJ Mulling Over a Stimulus Exit: ETFs in Focus
by Sanghamitra Saha
These Japan ETFs may gain if the BoJ manages to make an exit from its hefty stimulus program.